Grace Therapeutics (GRCE) Receivables - Accured (2019 - 2023)
Grace Therapeutics (GRCE) posted Receivables - Accured of $143000.0 for Q1 2023, up 101.41% sequentially from $71000.0 in Q1 2022, and up 101.41% YoY from $71000.0 in Q1 2022.
Grace Therapeutics (GRCE) Receivables - Accured (2019 - 2023) Analysis & Trends
Grace Therapeutics has reported Receivables - Accured for 3 years, with the latest figure at $143000.0 in Q1 2023.
- Quarterly Receivables - Accured rose 101.41% year-over-year to $143000.0 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $143000.0 (up 101.41% YoY) and the FY2023 annual result came in at $143000.0, up 101.41% from the prior year.
- Receivables - Accured rose to $143000.0 in Q1 2023 per GRCE's latest filing, from $71000.0 in the prior quarter.
- Over five years, Receivables - Accured peaked at $143000.0 in Q1 2023 and troughed at $60155.1 in Q1 2019.
- A 3-year average of $91385.0 and a median of $71000.0 in 2022 frame the typical range for Receivables - Accured.
- The widest YoY moves for Receivables - Accured: up 101.41% in 2023, down 101.41% in 2023.
- Over 3 years, Receivables - Accured stood at $60155.1 in 2019, then gained by 18.03% to $71000.0 in 2022, then jumped by 101.41% to $143000.0 in 2023.
- According to Business Quant data, Receivables - Accured over the past three periods registered $143000.0, $71000.0, and $60155.1 for Q1 2023, Q1 2022, and Q1 2019 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables - Accured (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Grace Therapeutics | 37.04 Mn | 37.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 143,000.00 |
| Mar 31, 2023 | 143,000.00 |
| Mar 31, 2022 | 71,000.00 |
| Mar 31, 2022 | 71,000.00 |
| Mar 31, 2019 | 60,155.15 |
| Mar 31, 2019 | 60,155.15 |